EVOKE PHARMA, INC. Operating Lease Liability
EVOKE PHARMA, INC. had Operating Lease Liability of $112.35 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-11-13
- 2025-09-30: Operating Lease, Liability $112.35K.
- 2025-06-30: Operating Lease, Liability $128.80K.
- 2025-03-31: Operating Lease, Liability $144.84K.
- 2024-12-31: Operating Lease, Liability $160.49K.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-09-30 | $112.35K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $128.80K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $144.84K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $160.49K 10-K · filed 2025-03-13 |
| 2019-01-01 | $136.00K 10-Q · filed 2019-11-07 |